Last $39.66 USD
Change Today +0.52 / 1.33%
Volume 266.1K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barclay A. Phillips

Former Director, Member of Audit Committee and Member of Nominations & Governance Committee, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 2 different organizations across 6 different industries.

See Board Relationships
51$481,646

Background*

Mr. Barclay A. Phillips, known as Buck, has been the Chief Financial Officer and Senior Vice President of Hologic Surgical Products, Limited Partnership since June 24, 2013 and serves as its Principal Accounting Officer and Treasurer. Mr. Phillips has been Managing Director of Vector Fund Management, L.P., a venture capital firm focused specifically on healthcare technology, since 1999. He served as the Chief Financial Officer and Senior Vice President of Micromet, Inc. ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

Director
2000-Present
Director
2000-2008
Former Chief Financial Officer, Principal Accounting Officer and Senior Vice President
2000-N/A
Former Director, Member of Audit Committee and Member of Nominating and Corporate Governance Committee
2004-2009
Former Director, Member of Audit Committee and Member of Nominations & Governance Committee

Education*

BA
University of Colorado–Boulder

Other Affiliations*

Annual Compensation*

Salary$156,346
Total Annual Compensation$156,346

Stock Options*

All Other Compensation$4,315
Unexercisable Options300,000
Unexercisable Options Value$927,000
Total Value of Options$927,000
Total Number of Options300,000

Total Compensation*

Total Annual Cash Compensation$218,306
Total Short Term Compensation$156,346
Other Long Term Compensation$4,315
Total Calculated Compensation$481,646
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $39.66 USD +0.52

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$557.7K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.